| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_962adbf7d50e742218f3d536a63df612 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 |
| filingDate |
2009-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a33f80e7068ffaaa02a0b62b97d5d112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fff69e4cc6bde25509f34ae79f9f728c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c747557f6d5760edf5eb2643c9d5cab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06e97d3ef7cea048f6831d0b88a2de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afdb1a633ba46b2e506d5bbea7643c56 |
| publicationDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009230345-B2 |
| titleOfInvention |
Oral preparation |
| abstract |
The oral preparation of this invention has a drug-containing layer that contains the drug, disintegration-controlling layers provided on both surfaces of the drug-containing layer, and gel-forming layers provided on each disintegration-controlling layer of the drug-containing layer and which swell by absorbing water to form a gel. Each disintegration-controlling layer is characterized by the fact that it is composed of materials including a gastrosoluble material that dissolves when coming into contact with gastric juice. The oral preparation of this invention is easy to swallow and can release the drug at targeted sites of the body, particularly in the stomach. |
| priorityDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |